Primary Central Nervous System Lymphoma in a Patient with Down Syndrome

被引：0

作者：

Shibata, Ami ^{[1
,2
]}

Yamaguchi, Fumio ^{[3
,4
]}

Sasaki, Kazuma ^{[2
]}

Yokobori, Shoji ^{[2
]}

Morita, Akio ^{[3
]}

机构：

[1] Tama Nagayama Hosp, Dept Emergency & Crit Care Med, Nippon Med Sch, Tokyo, Japan

[2] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo, Japan

[3] Nippon Med Sch, Dept Neurosurg Surg, Tokyo, Japan

[4] Nippon Med Sch, Dept Neurosurg Community Hlth, Tokyo, Japan

来源：

JOURNAL OF NIPPON MEDICAL SCHOOL | 2023年 / 90卷 / 04期

关键词：

brain tumor; Down syndrome; lymphoma; PCNSL; primary central nervous system lymphoma; EPIDEMIOLOGY; TUMORS;

D O I：

10.1272/jnms.JNMS.2023_90-502

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Intracranial tumors are rare in persons with Down syndrome. Although germ cell tumors and gliomas have been reported in Down syndrome, primary central nervous system lymphoma (PCNSL) has not. We report a case of PCNSL in a 48-year-old man with Down syndrome and no history of malignant tumors. He visited our hospital for evaluation of left hemiparesis and gait disturbance. A thorough examination revealed brain tumors, and analysis of a biopsy specimen of the tumor confirmed a diagnosis of PCNSL. The final pathological diagnosis was diffuse large B-cell lymphoma of the central nervous system. Chemotherapy with rituximab, methotrexate, procarbazine, and vincristine was administered, and whole-brain irradiation was planned in conjunction with chemotherapy. It is unclear whether chromosomal abnormalities related to Down syndrome were involved in the development of PCNSL. Further molecular biological analysis may clarify the mechanism of combined Down syndrome and PCNSL.

引用

页码：346 / 350

页数：5

共 27 条

[1] Chromosome 21-Encoded microRNAs (mRNAs): Impact on Down's Syndrome and Trisomy-21 Linked Disease
Alexandrov, P. N.
Percy, M. E.
Lukiw, Walter J.
[J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 2018, 38 (03) : 769 - 774
[2] Down syndrome: an insight of the disease
Asim, Ambreen
Kumar, Ashok
Muthuswamy, Srinivasan
Jain, Shalu
Agarwal, Sarita
[J]. JOURNAL OF BIOMEDICAL SCIENCE, 2015, 22
[3] Primary Central Nervous System Lymphoma
Doucet, Stephane
Kumthekar, Priya
Raizer, Jeffrey
[J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (02) : 185 - 197
[4] Benign and malignant tumors in Down syndrome: Analysis of the 1514 autopsied cases in Japan
Ehara, Hiroaki
Ohno, Kousaku
Ito, Hisao
[J]. PEDIATRICS INTERNATIONAL, 2011, 53 (01) : 72 - 77
[5] Kaczorowska N, 2019, ADV CLIN EXP MED, V28, P1587, DOI [10.17219/acem/111410, 10.17219/acem/112785]
[6] Abnormal MicroRNA Expression in Ts65Dn Hippocampus and Whole Blood: Contributions to Down Syndrome Phenotypes
Keck-Wherley, Jennifer
Grover, Deepak
Bhattacharyya, Sharmistha
Xu, Xiufen
Holman, Derek
Lombardini, Eric D.
Verma, Ranjana
Biswas, Roopa
Galdzicki, Zygmunt
[J]. DEVELOPMENTAL NEUROSCIENCE, 2011, 33 (05) : 451 - 467
[7] The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome
Lee, P.
Bhansali, R.
Izraeli, S.
Hijiya, N.
Crispino, J. D.
[J]. LEUKEMIA, 2016, 30 (09) : 1816 - 1823
[8] Primary central nervous system lymphoma
Loew, Sarah
Han, Catherine H.
Batchelor, Tracy T.
[J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
[9] Lukas RV, 2018, ONCOLOGY-NY, V32, P17
[10] The possible effect of microRNA-155 (miR-155) and BACE1 inhibitors in the memory of patients with down syndrome and Alzheimer's disease: Design, synthesis, virtual screening, molecular modeling and biological evaluations
Mahernia, Shabnam
Hassanzadeh, Malihe
Adib, Mehdi
Peytam, Fariba
Haghighijoo, Zahra
Iraji, Aida
Mahdavi, Mohammad
Edraki, Najmeh
Amanlou, Massoud
[J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (13) : 5803 - 5814

← 1 2 3 →